The rise in GLP-1 use among young women raises concerns about contraceptive efficacy and potential pregnancy risks. Learn ...

Though retrospective, the findings provide ‘compelling’ evidence that GLP-1 receptor agonists may help prevent development ...

Despite the $1,000-per-dose price tag, GLP-1s may offer long-term ROI by lowering chronic disease rates GLP-1 weight loss ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

With GLP-1 shortage officially over, patients who relied on compounded copies have only bad options to choose from ...

CVS Caremark has selected Novo Nordisk’s Wegovy as the preferred GLP-1 medication for its largest commercial template formularies, effective July 1. In March, Novo Nordisk launched NovoCare Pharmacy ...

Keeping up with the GLP-1 area is a full-time job by itself. First off, you have the recent development that these drugs are ...

Some telehealth companies that offered compounded GLP-1s have disappeared altogether. Others are pursuing strategies that ...

How can policy makers and health care leaders ensure affordable, equitable access to GLP-1 medications while managing their ...

What to Eat Before a Workout. Before a workout, make sure to get enough energizing carbs — even a small carb-based snack can ...

Proportion of adult managed care organizations with availability varied from 24 to 100 percent for SGLT2 inhibitors, 0 to 99 percent for GLP-1 receptor agonists.

Spending on Ozempic, Wegovy and other similar prescriptions soared 500 percent in five years, according to a research letter.